Based on the analysis of LENSAR's profitability, liquidity, and operating efficiency, LENSAR Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. At this time, LENSAR's Common Stock Shares Outstanding is relatively stable compared to the past year. As of 03/19/2025, Liabilities And Stockholders Equity is likely to grow to about 68.2 M, while Total Current Liabilities is likely to drop slightly above 11.1 M. Key indicators impacting LENSAR's financial strength include:
The financial analysis of LENSAR is a critical element in measuring its lifeblood. Investors should not minimize LENSAR's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
LENSAR competes with Rxsight, Axogen, Treace Medical, Pulmonx Corp, and Orthofix Medical. LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida. LENSAR operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 110 people.
The reason investors look at the income statement is to determine what LENSAR's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining LENSAR's current stock value. Our valuation model uses many indicators to compare LENSAR value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LENSAR competition to find correlations between indicators driving LENSAR's intrinsic value. More Info.
LENSAR Inc is rated below average in return on equity category among its peers. It is rated fourth overall in return on asset category among its peers . At this time, LENSAR's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value LENSAR by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
LENSAR Inc Systematic Risk
LENSAR's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. LENSAR volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on LENSAR Inc correlated with the market. If Beta is less than 0 LENSAR generally moves in the opposite direction as compared to the market. If LENSAR Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one LENSAR Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of LENSAR is generally in the same direction as the market. If Beta > 1 LENSAR moves generally in the same direction as, but more than the movement of the benchmark.
LENSAR Thematic Clasifications
LENSAR Inc is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
Today, most investors in LENSAR Stock are looking for potential investment opportunities by analyzing not only static indicators but also various LENSAR's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of LENSAR growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of LENSAR help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of LENSAR Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of LENSAR Inc based on widely used predictive technical indicators. In general, we focus on analyzing LENSAR Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build LENSAR's daily price indicators and compare them against related drivers.
When running LENSAR's price analysis, check to measure LENSAR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENSAR is operating at the current time. Most of LENSAR's value examination focuses on studying past and present price action to predict the probability of LENSAR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENSAR's price. Additionally, you may evaluate how the addition of LENSAR to your portfolios can decrease your overall portfolio volatility.